GL1X · GenesisL1 explorer

Research workbench

A 1.4 ångström crystal structure for the hypoxanthine phosphoribosyltransferase of trypanosoma cruzi

Analyse A 1.4 ångström crystal structure for the hypoxanthine phosphoribosyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1TC1
Type
protein
Length
361 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.41
Source
Trypanosoma cruzi
Molecule
Protein (hypoxanthine phosphoribosyltransferase)
EC
2.4.2.8
UniProt
Q27796
Ligands
FMB
Pockets
5 · best druggability 0.58

Structure

x-ray diffraction · resolution 1.41 · 2 distinct chains · 25% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein (hypoxanthine phosphoribosyltransferase) (EC 2.4.2.8)protein17525% helix, 34% strandQ27796
BProtein (hypoxanthine phosphoribosyltransferase) (EC 2.4.2.8)protein18625% helix, 33% strandQ27796

Ligands and binding sites

  • FMB · Formycin B · ligand · 2 copies · chains A, B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13860.580.7542FMB, MES
23050.570.7634FMB, MES
31390.560.8321empty
4750.400.7918empty
5690.340.7617empty

Interfaces

1 interface between chains.

  • A–B · 1564 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 1TC1 · A 1.4 ångström crystal structure for the hypoxanthine phosphoribosyltransferase of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.